Report Description

Global precision cardiology market is anticipated to register growth at an impressive CAGR in the forecast period, 2023-2027. The market growth can be attributed to the rising geriatric population as they are more susceptible to such ailments. In addition, the growing prevalence of cardiovascular diseases, owing to the adoption of unhealthy and sedentary lifestyles such as eating junk and processed foods, restricted physical activities, and high alcohol consumption, are creating greater need for precision cardiology.

Precision cardiology (PM) refers to an integrative approach of dealing with cardiovascular disease prevention and treatment. This approach proposes the customization of healthcare treatments, procedures, and medicines depending on the patient’s genetics, lifestyle, and other molecular or cellular analysis. Precision cardiology involves treatment tailored to a subgroup of patients with shared characteristics for improved outcomes. Besides, growing awareness regarding precision cardiology, coupled with its increased adoption by healthcare providers, is fueling the market growth. This is primarily because, precision cardiology helps healthcare providers in better understanding several things such as the patient’s environment, lifestyle, and heredity, which might positively influence the result of the treatment. Thus, healthcare providers across the globe are increasingly employing precision cardiology to accurately predict the right, safe, and most effective treatment for the patient.

Artificial Intelligence in Precision Cardiology Fuels the Market Growth

The integration of AI with precision cardiology is acting as a major growth-inducing factor for the global precision cardiology market. Machine learning algorithms are utilized to analyze and draw inferences from the huge amounts of data generated from patients and healthcare institutions. AI techniques are also used in genome sequencing and precision cardiovascular medicine to understand phenotypes and genotypes in the existing diseases and improve the quality of patient care. This signifies that the rate of hospital readmissions and mortality will reduce over the coming years leveraging, hence making the overall healthcare cost-effective for the patients.

Rising Prevalence of Cardiovascular Diseases Boost the Market Growth

The global precision technology market is witnessing a robust growth due to the rising cases of cardiovascular diseases such as diabetes, hypertension, and cardiovascular disorders such as coronary artery disease (CAD). According to a report, in 2020, nearly 697,000 people in the United States died from heart disease, that equals to one in every five deaths. As a result, the patients are increasingly inclining towards early detection and screening in order to prevent the disease from becoming fatal. In addition, the decreasing cost of sequencing is providing a positive outlook to the market. Furthermore, several leading market players are focusing on the development of precision cardiology tests based on advanced sequencing technologies to support healthcare professionals in taking informed decisions in the field of cardiovascular care. All the aforementioned factors are anticipated to propel the global precision cardiology market in the coming years.


DOWNLAOD FREE SAMPLE REPORT

Market Segmentation

The global precision cardiology market is segmented on the basis of offering, sample type, technology, application, end user, competitive landscape, and regional distribution. Based on offering, the market is bifurcated into products and services. By sample type, the market is fragmented between blood and non-blood. By technology, the market is divided among sequencing, polymerase chain reaction, microarray, and others. Based on the application, the market is segmented into cardiomyopathy, arrhythmia, aortopathy and vascular diseases, and others. On the basis of end user, the global market is segmented hospitals & clinics, academic & research institutions, and others. The market analysis also studies the regional segmentation, divided among North America, Europe, Asia Pacific, Middle East and Africa, South America. In terms of country, the United States is expected to hold a significant share in the global precision cardiology market, owing to the advanced healthcare infrastructure and increasing mortality rates from cardiovascular disorders in the country.  

Company Profile

Eurofins Genomics LLC, Laboratory Corporation of America Holdings, Thermos Fischer Scientific, Inc., PerkinElmer, Inc., Sema4 OpCo, Inc., Quest Diagnostics Inc., OraSure Technologies, Inc., OPKO Health, Inc., Invitae Corporation, Illumina, Inc., Fulgent Genetics, Inc., Exact Sciences Corporation, CENTOGENE N.V., Konica Minolta, Inc., and Devyser Diagnostics AB are the leading market players in the global precision cardiology market.

Attribute

Details

Base Year

2021

Historical Data

2017 – 2020

Estimated Year

2022

Forecast Period

2023 – 2027

Quantitative Units

Revenue in USD Million, and CAGR for 2017-2021 and 2022-2027

Report coverage

Revenue forecast, volume forecast, company share, competitive landscape, growth factors, and trends

Segments covered

·         Offering

·         Sample Type

·         Technology

·         Application

·         End User

Regional scope

North America, Europe, Asia Pacific, Middle east and Africa, South America

Key companies profiled

Eurofins Genomics LLC, Laboratory Corporation of America Holdings, Thermos Fischer Scientific, Inc., PerkinElmer, Inc., Sema4 OpCo, Inc., Quest Diagnostics Inc., OraSure Technologies, Inc., OPKO Health, Inc., Invitae Corporation, Illumina, Inc., Fulgent Genetics, Inc., Exact Sciences Corporation, CENTOGENE N.V., Konica Minolta, Inc., and Devyser Diagnostics AB

Customization scope

10% free report customization with purchase. Addition or alteration to country, regional & segment scope.

Pricing and purchase options

Avail customized purchase options to meet your exact research needs. Explore purchase options

Delivery Format

PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

 

Report Scope:

In this report, the global precision cardiology market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

  • Precision Cardiology Market, By Offering:
    • Products
    • Services
  • Precision Cardiology Market, By Sample Type:
    • Blood
    • Non-Blood
  • Precision Cardiology Market, By Technology:
    • Sequencing
    • Polymerase Chain Reaction
    • Microarray
    • Others
  • Precision Cardiology Market, By Application:

o   Cardiomyopathy

o   Arrhythmia

o   Aortopathy and Vascular Diseases

o   Others

  • Precision Cardiology Market, By End User

o   Hospitals & Clinics

o   Academic & Research Institutions

o   Others

  • Precision Cardiology Market, By Region:

o   North America

o   Europe

o   Asia Pacific

o   Middle East and Africa

o   South America

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in Global Precision Cardiology Market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Global Precision Cardiology Market is an upcoming report to be released soon. If you wish an early delivery of this report or want to confirm the date of release, please contact us at [email protected]  

Table of content

1.    Product Overview

2.    Research Methodology

3.    Executive Summary

4.    Impact of COVID-19 on Global Precision Cardiology Market

5.    Voice of Customer

5.1.  Precision Cardiology Awareness

5.2.  Cardiovascular Diseases Prevalence, By Gender

5.3.  Cardiovascular Diseases Prevalence, By Age Group

5.4.  Cardiovascular Diseases Prevalence, Region

5.5.  Benefits of Using Precision Medicine in Cardiology

6.    Clinical Trial Analysis

7.    Patent Analysis

8.    Global Precision Cardiology Market Outlook

8.1.  Market Size & Forecast

8.1.1.     By Value

8.2.  Market Share & Forecast

8.2.1.     By Offering (Products v/s Services)

8.2.2.     By Sample Type (Blood v/s Non Blood)

8.2.3.     By Technology (Sequencing, Polymerase Chain Reaction, Microarray, Others)

8.2.4.     By Application (Cardiomyopathy, Arrhythmia, Aortopathy and Vascular Diseases, Others)

8.2.5.     By End User (Hospitals & Clinics, Academic & Research Institutions, Others)

8.2.6.     By Region

8.2.7.     By Company (2021)

8.3.  Product Market Map

9.    North America Precision Cardiology Market Outlook

9.1.  Market Size & Forecast          

9.1.1.     By Value

9.2.  Market Share & Forecast

9.2.1.     By Offering

9.2.2.     By Sample Type

9.2.3.     By Technology

9.2.4.     By Application

9.2.5.     By End User

9.2.6.     By Country

9.3.  North America: Country Analysis

9.3.1.     United States Precision Cardiology Market Outlook

9.3.1.1.         Market Size & Forecast

9.3.1.1.1.             By Value

9.3.1.2.         Market Share & Forecast

9.3.1.2.1.             By Offering

9.3.1.2.2.             By Sample Type

9.3.1.2.3.             By Technology

9.3.1.2.4.             By Application

9.3.1.2.5.             By End User

9.3.2.     Mexico Precision Cardiology Market Outlook

9.3.2.1.         Market Size & Forecast

9.3.2.1.1.             By Value

9.3.2.2.         Market Share & Forecast

9.3.2.2.1.             By Offering

9.3.2.2.2.             By Sample Type

9.3.2.2.3.             By Technology

9.3.2.2.4.             By Application

9.3.2.2.5.             By End User

9.3.3.     Canada Precision Cardiology Market Outlook

9.3.3.1.         Market Size & Forecast

9.3.3.1.1.             By Value

9.3.3.2.         Market Share & Forecast

9.3.3.2.1.             By Offering

9.3.3.2.2.             By Sample Type

9.3.3.2.3.             By Technology

9.3.3.2.4.             By Application

9.3.3.2.5.             By End User

10.  Europe Precision Cardiology Market Outlook

10.1.              Market Size & Forecast

10.1.1.  By Value

10.2.              Market Share & Forecast

10.2.1.  By Offering

10.2.2.  By Sample Type

10.2.3.  By Technology

10.2.4.  By Application

10.2.5.  By End User

10.2.6.  By Country

10.3.              Europe: Country Analysis

10.3.1.  France Precision Cardiology Market Outlook

10.3.1.1.      Market Size & Forecast

10.3.1.1.1.           By Value

10.3.1.2.      Market Share & Forecast

10.3.1.2.1.           By Offering

10.3.1.2.2.           By Sample Type

10.3.1.2.3.           By Technology

10.3.1.2.4.           By Application

10.3.1.2.5.           By End User

10.3.2.  Germany Precision Cardiology Market Outlook

10.3.2.1.      Market Size & Forecast

10.3.2.1.1.           By Value

10.3.2.2.      Market Share & Forecast

10.3.2.2.1.           By Offering

10.3.2.2.2.           By Sample Type

10.3.2.2.3.           By Technology

10.3.2.2.4.           By Application

10.3.2.2.5.           By End User

10.3.3.  United Kingdom Precision Cardiology Market Outlook

10.3.3.1.      Market Size & Forecast

10.3.3.1.1.           By Value

10.3.3.2.      Market Share & Forecast

10.3.3.2.1.           By Offering

10.3.3.2.2.           By Sample Type

10.3.3.2.3.           By Technology

10.3.3.2.4.           By Application

10.3.3.2.5.           By End User

10.3.3.2.6.           By Ecosystem

10.3.3.2.7.           By Application

10.3.4.  Italy Precision Cardiology Market Outlook

10.3.4.1.      Market Size & Forecast

10.3.4.1.1.           By Value

10.3.4.2.      Market Share & Forecast

10.3.4.2.1.           By Offering

10.3.4.2.2.           By Sample Type

10.3.4.2.3.           By Technology

10.3.4.2.4.           By Application

10.3.4.2.5.           By End User

10.3.5.  Spain Precision Cardiology Market Outlook

10.3.5.1.      Market Size & Forecast

10.3.5.1.1.           By Value

10.3.5.2.      Market Share & Forecast

10.3.5.2.1.           B By Offering

10.3.5.2.2.           By Sample Type

10.3.5.2.3.           By Technology

10.3.5.2.4.           By Application

10.3.5.2.5.           By End User

10.3.5.2.6.           y Ecosystem

10.3.5.2.7.           By Application

11.  Asia-Pacific Precision Cardiology Market Outlook

11.1.              Market Size & Forecast

11.1.1.  By Value

11.2.              Market Share & Forecast

11.2.1.  By Offering

11.2.2.  By Sample Type

11.2.3.  By Technology

11.2.4.  By Application

11.2.5.  By End User

11.2.6.  By Country

11.3.              Asia-Pacific: Country Analysis

11.3.1.  China Precision Cardiology Market Outlook

11.3.1.1.      Market Size & Forecast

11.3.1.1.1.           By Value

11.3.1.2.      Market Share & Forecast

11.3.1.2.1.           By Offering

11.3.1.2.2.           By Sample Type

11.3.1.2.3.           By Technology

11.3.1.2.4.           By Application

11.3.1.2.5.           By End User

11.3.2.  India Precision Cardiology Market Outlook

11.3.2.1.      Market Size & Forecast

11.3.2.1.1.           By Value

11.3.2.2.      Market Share & Forecast

11.3.2.2.1.           By Offering

11.3.2.2.2.           By Sample Type

11.3.2.2.3.           By Technology

11.3.2.2.4.           By Application

11.3.2.2.5.           By End User

11.3.3.  South Korea Precision Cardiology Market Outlook

11.3.3.1.      Market Size & Forecast

11.3.3.1.1.           By Value

11.3.3.2.      Market Share & Forecast

11.3.3.2.1.           By Offering

11.3.3.2.2.           By Sample Type

11.3.3.2.3.           By Technology

11.3.3.2.4.           By Application

11.3.3.2.5.           By End User

11.3.4.  Japan Precision Cardiology Market Outlook

11.3.4.1.      Market Size & Forecast

11.3.4.1.1.           By Value

11.3.4.2.      Market Share & Forecast

11.3.4.2.1.           By Offering

11.3.4.2.2.           By Sample Type

11.3.4.2.3.           By Technology

11.3.4.2.4.           By Application

11.3.4.2.5.           By End User

11.3.5.  Australia Precision Cardiology Market Outlook

11.3.5.1.      Market Size & Forecast

11.3.5.1.1.           By Value

11.3.5.2.      Market Share & Forecast

11.3.5.2.1.           By Offering

11.3.5.2.2.           By Sample Type

11.3.5.2.3.           By Technology

11.3.5.2.4.           By Application

11.3.5.2.5.           By End User

12.  South America Precision Cardiology Market Outlook

12.1.              Market Size & Forecast

12.1.1.  By Value

12.2.              Market Share & Forecast

12.2.1.  By Offering

12.2.2.  By Sample Type

12.2.3.  By Technology

12.2.4.  By Application

12.2.5.  By End User

12.2.6.  By Country

12.3.              South America: Country Analysis

12.3.1.  Brazil Precision Cardiology Market Outlook

12.3.1.1.      Market Size & Forecast

12.3.1.1.1.           By Value

12.3.1.2.      Market Share & Forecast

12.3.1.2.1.           By Offering

12.3.1.2.2.           By Sample Type

12.3.1.2.3.           By Technology

12.3.1.2.4.           By Application

12.3.1.2.5.           By End User

12.3.2.  Argentina Precision Cardiology Market Outlook

12.3.2.1.      Market Size & Forecast

12.3.2.1.1.           By Value

12.3.2.2.      Market Share & Forecast

12.3.2.2.1.           By Offering

12.3.2.2.2.           By Sample Type

12.3.2.2.3.           By Technology

12.3.2.2.4.           By Application

12.3.2.2.5.           By End User

12.3.3.  Colombia Precision Cardiology Market Outlook

12.3.3.1.      Market Size & Forecast

12.3.3.1.1.           By Value

12.3.3.2.      Market Share & Forecast

12.3.3.2.1.           By Offering

12.3.3.2.2.           By Sample Type

12.3.3.2.3.           By Technology

12.3.3.2.4.           By Application

12.3.3.2.5.           By End User

13.  Middle East and Africa Precision Cardiology Market Outlook

13.1.              Market Size & Forecast

13.1.1.  By Value

13.2.              Market Share & Forecast

13.2.1.  By Offering

13.2.2.  By Sample Type

13.2.3.  By Technology

13.2.4.  By Application

13.2.5.  By End User

13.2.6.  By Country

13.3.              MEA: Country Analysis

13.3.1.  South Africa Precision Cardiology Market Outlook

13.3.1.1.      Market Size & Forecast

13.3.1.1.1.           By Value

13.3.1.2.      Market Share & Forecast

13.3.1.2.1.           By Offering

13.3.1.2.2.           By Sample Type

13.3.1.2.3.           By Technology

13.3.1.2.4.           By Application

13.3.1.2.5.           By End User

13.3.2.  Saudi Arabia Precision Cardiology Market Outlook

13.3.2.1.      Market Size & Forecast

13.3.2.1.1.           By Value

13.3.2.2.      Market Share & Forecast

13.3.2.2.1.           By Offering

13.3.2.2.2.           By Sample Type

13.3.2.2.3.           By Technology

13.3.2.2.4.           By Application

13.3.2.2.5.           By End User

13.3.3.  UAE Precision Cardiology Market Outlook

13.3.3.1.      Market Size & Forecast

13.3.3.1.1.           By Value

13.3.3.2.      Market Share & Forecast

13.3.3.2.1.           By Offering

13.3.3.2.2.           By Sample Type

13.3.3.2.3.           By Technology

13.3.3.2.4.           By Application

13.3.3.2.5.           By End User

14.  Market Dynamics

14.1.              Drivers

14.2.              Challenges

15.  Market Trends & Developments

16.  SWOT Analysis: Global Precision Cardiology Market

17.  Competitive Landscape (Inclusive of SWOT Analysis of Players Profiled)

17.1.              Eurofins Genomics LLC

17.2.              Laboratory Corporation of America Holdings

17.3.              Thermos Fischer Scientific, Inc.

17.4.              PerkinElmer, Inc.

17.5.              Sema4 OpCo, Inc.

17.6.              Quest Diagnostics Inc.

17.7.              OraSure Technologies, Inc.

17.8.              OPKO Health, Inc.

17.9.              Invitae Corporation

17.10.            Illumina, Inc.

17.11.            Fulgent Genetics, Inc.

17.12.            Exact Sciences Corporation

17.13.            CENTOGENE N.V.

17.14.            Konica Minolta, Inc.

17.15.            Devyser Diagnostics AB

18.  Strategic Recommendations 

(Note: The companies list can be customized based on the client requirements.)

Figures and Tables

Frequently asked questions

down-arrow

The global precision cardiology market is primarily driven by the growing prevalence of cardiovascular diseases such as diabetes, coronary artery disease, heart attacks due to the adoption of sedentary lifestyle.

down-arrow

On the basis of sample type, the market is divided between blood and non-blood sample. Among these, the sample type is anticipated to hold a significant market share over the coming years.

down-arrow

Eurofins Genomics LLC, Laboratory Corporation of America Holdings, Thermos Fischer Scientific, Inc., PerkinElmer, Inc., Sema4 OpCo, Inc., Quest Diagnostics Inc., OraSure Technologies, Inc., OPKO Health, Inc., Invitae Corporation, Illumina, Inc., Fulgent Genetics, Inc., Exact Sciences Corporation, CENTOGENE N.V., Konica Minolta, Inc., and Devyser Diagnostics AB are the leading market players in the global precision cardiology market.

down-arrow

Main challenges that restrict the growth of the global precision cardiology market are lack of regulatory policies in the precision cardiology field and lack of high complexity testing facilities.

profile

Sakshi Bajaal

Business Consultant
Press Release

Precision cardiology Market is Anticipated to Register Impressive Growth Through 2027

Aug, 2022

Increasing prevalence of cardiovascular diseases along with the launch of optimized treatment solutions to meet the diverse treatment needs of CVD patient’s is driving the growth of global precision